BriaCell has a manufacturing agreement with FUJIFILM Biotechnologies California, a contract development and manufacturing organization (CDMO), to support the Phase 3 clinical development and potential commercial supply of its lead clinical candidate, Bria-IMT. FUJIFILM Biotechnologies California and the UC Davis GMP facility have developed a frozen formulation process for Bria-IMT cells, encompassing growth, harvesting, irradiation, and cryopreservation. On May 28, 2024, BriaCell announced a clinical supply agreement with BeiGene for the Bria-OTS first-in-human study, which will evaluate Bria-OTS in combination with the anti-PD-1 antibody tislelizumab in patients with metastatic breast cancer. Other suppliers referenced in company filings include BeiGene, Fuji, FujiFilm Diosynth Biotechnology, KBI, UC Davis, Waisman Biomanufacturing, and Waisman Biomanufacturing at the University of Wisconsin-Madison.
Briacell Therapeutics's Comment on Supply Chain
BriaCell has a manufacturing agreement with FUJIFILM Biotechnologies California, a contract development and manufacturing organization (CDMO), to support the Phase 3 clinical development and potential commercial supply of its lead clinical candidate, Bria-IMT. FUJIFILM Biotechnologies California and the UC Davis GMP facility have developed a frozen formulation process for Bria-IMT cells, encompassing growth, harvesting, irradiation, and cryopreservation. On May 28, 2024, BriaCell announced a clinical supply agreement with BeiGene for the Bria-OTS first-in-human study, which will evaluate Bria-OTS in combination with the anti-PD-1 antibody tislelizumab in patients with metastatic breast cancer. Other suppliers referenced in company filings include BeiGene, Fuji, FujiFilm Diosynth Biotechnology, KBI, UC Davis, Waisman Biomanufacturing, and Waisman Biomanufacturing at the University of Wisconsin-Madison.
Sources:
Briacell Therapeutics Corp 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Briacell Therapeutics Corp ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
